Muscle News and Research

RSS

Researchers examine link between non-restorative sleep and widespread pain among older adults

Researchers in the U.K. report that non-restorative sleep is the strongest, independent predictor of widespread pain onset among adults over the age of 50. According to the study published in Arthritis & Rheumatology (formerly Arthritis & Rheumatism), a journal of the American College of Rheumatology (ACR), anxiety, memory impairment, and poor physical health among older adults may also increase the risk of developing widespread pain.

13 Feb 2014

Engineers turn cells common in scar tissue into colonies of beating heart cells

Poets and physicians know that a scarred heart cannot beat the way it used to, but the science of reprogramming cells offers hope--for the physical heart, at least.

13 Feb 2014

Long-term physical activity improves cardiovascular health by targeting heart cells' powerhouses

Whether lifting weights in a gym or just walking around the block, exercise has many benefits, such as helping people lose weight and build stronger muscles. Some studies suggest that it may reduce the risk of developing cancer and other diseases.

13 Feb 2014

First evidence of link between prenatal vitamin A deficiency and postnatal asthma

A team of Columbia University Medical Center (CUMC) investigators led by Wellington V. Cardoso, MD, PhD, has found the first direct evidence of a link between prenatal vitamin A deficiency and postnatal airway hyperresponsiveness, a hallmark of asthma.

13 Feb 2014

FDA approves InControl Medical's InToneMV device for treatment of female urinary incontinence

InControl Medical, LLC, a women's health company focusing on female urinary incontinence, has received FDA clearance for their proprietary, patented, InToneMV, providing women who suffer with vaginal atrophy a smaller, more comfortable medical device for the treatment of stress, urge and mixed female urinary incontinence without surgery or drugs.

12 Feb 2014

Biologists demonstrate highly effective method for delivering HIV-fighting antibodies

In 2011, biologists at the California Institute of Technology (Caltech) demonstrated a highly effective method for delivering HIV-fighting antibodies to mice-a treatment that protected the mice from infection by a laboratory strain of HIV delivered intravenously.

12 Feb 2014

Researchers demonstrate new approach to treating muscular dystrophy

Researchers at Washington University School of Medicine in St. Louis have demonstrated a new approach to treating muscular dystrophy. Mice with a form of this muscle-weakening disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.

12 Feb 2014

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.

11 Feb 2014

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.

11 Feb 2014

Study findings suggest potential targets for treating HCV

The hepatitis C virus (HCV) has a previously unrecognized tactic to outwit antiviral responses and sustain a long-term infection. It also turns out that some people are genetically equipped with a strong countermeasure to the virus' attempt to weaken the attack on it.

11 Feb 2014

Body regulates hormone crucial for motivation and stress response, reveals research

New research has revealed a previously unknown mechanism in the body which regulates a hormone that is crucial for motivation, stress responses and control of blood pressure, pain and appetite. The breakthrough could be used to design drugs to help fight health problems connected with these functions in the future.

11 Feb 2014

Study on heart attacks identifies potential new treatment target for heart disease

Research led by David Lefer, PhD, Professor and Director of the Cardiovascular Center of Excellence at LSU Health Sciences Center New Orleans School of Medicine, demonstrates for the first time cross-talk between two protective signaling molecules during a heart attack.

11 Feb 2014

Study looks at effects of exercise on heart health in patients with chronic kidney disease

A Leicester doctor has become the first renal physician in the country to be awarded the National Institute for Health Research (NIHR) Clinician Scientist Award. The fellowship, worth more than £1 million, will fund a five-year study into the effects of exercise on heart disease in patients with chronic kidney disease who are on dialysis.

11 Feb 2014

UCLA researchers awarded $6M grant to explore new therapies for spinal-cord injuries

The National Institute of Biomedical Imaging and Bioengineering has awarded UCLA researchers Dr. Daniel Lu (Brentwood) and Dr. Reggie Edgerton (Bel Air) a $6 million, five-year grant to explore new therapies for the approximately 273,000 Americans living with spinal-cord injuries. Some 12,000 Americans suffer such injuries each year.

10 Feb 2014

NASA signs patent to develop novel biotechnology approaches that could have medical applications

NASA has signed two patent license agreements with GRoK Technologies LLC of Houston to help develop novel biotechnology approaches that could have multiple applications in space and on Earth.

10 Feb 2014

Ipsen’s phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

10 Feb 2014

DP stimulation in spinal cord-injured patients is successful in weaning patients from mechanical ventilators

A new study published in the Journal of Trauma and Acute Care Surgery finds that diaphragm pacing (DP) stimulation in spinal cord-injured patients is successful not only in weaning patients from mechanical ventilators but also in bridging patients to independent respiration, where they could breathe on their own without the aid of a ventilator or stimulation.

9 Feb 2014

Muscle News and Research

Researchers examine link between non-restorative sleep and widespread pain among older adults

Engineers turn cells common in scar tissue into colonies of beating heart cells

Long-term physical activity improves cardiovascular health by targeting heart cells' powerhouses

First evidence of link between prenatal vitamin A deficiency and postnatal asthma

FDA approves InControl Medical's InToneMV device for treatment of female urinary incontinence

Biologists demonstrate highly effective method for delivering HIV-fighting antibodies

Researchers demonstrate new approach to treating muscular dystrophy

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Study findings suggest potential targets for treating HCV

Body regulates hormone crucial for motivation and stress response, reveals research

Study on heart attacks identifies potential new treatment target for heart disease

Study looks at effects of exercise on heart health in patients with chronic kidney disease

UCLA researchers awarded $6M grant to explore new therapies for spinal-cord injuries

NASA signs patent to develop novel biotechnology approaches that could have medical applications

Ipsen’s phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

DP stimulation in spinal cord-injured patients is successful in weaning patients from mechanical ventilators

Researchers design microfluidic platform to see how cancer cells invade specific organs

Study offers new avenue to pursue in quest for desperately needed treatments for ALS

Bioengineer receives $1.4M grant to create nanoparticle system to shore up arterial walls

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News